Sidekick Partners With Bayer To Provide Digital Therapy Expansion For Peripheral Artery Disease

Nordic digital therapeutics company SidekickHealth has entered into a strategic partnership with global pharmaceutical and life sciences company Bayer to provide a digital medication management and lifestyle change platform to individuals suffering from Peripheral Artery Disease (PAD). Sidekick specializes in the creation of gamified digital therapeutic (DTx) solutions and programs, transforming chronic disease management across multiple therapeutic areas in alliance with key stakeholders in the pharmaceutical and health care industries.

Sidekick and Bayer have agreed to launch the program in Sweden, with the aim to roll it out across other European markets, collaborating with key opinion leaders and clinical experts . . .